CFO, COO
2024-07-23–present
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2024-07-23–present
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
CFO, COO
2024-07-23–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | BridgeBio Pharma, Inc. (BBIO) | President and Chief Financial Officer | $675,589 | $5,832,369 |
| 2024 | BridgeBio Pharma, Inc. (BBIO) | President and Chief Financial Officer | $643,654 | $6,502,058 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.